Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)

Dorte Schou  Nørøxe; Sandra Wallerek; Jens Benn Sørensen

Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)

Dorte Schou Nørøxe, Sandra Wallerek, Jens Benn Sørensen

6 Citations (Scopus)

Abstract

We report on a retrospective, consecutive non-randomized group of patients who received bevacizumab plus chemotherapy without bevazicumab maintenance.

Original language	English
Journal	Anticancer Research
Volume	33
Issue number	8
Pages (from-to)	3275-8
Number of pages	4
ISSN	0250-7005
Publication status	Published - Aug 2013

Keywords

Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms
Maintenance Chemotherapy
Male
Middle Aged
Neoplasm Staging
Platinum
Vinblastine

Cite this

@article{916372a8bd8746c0b251e0844e520558,

title = "Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)",

abstract = "We report on a retrospective, consecutive non-randomized group of patients who received bevacizumab plus chemotherapy without bevazicumab maintenance.",

keywords = "Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Lung Neoplasms, Maintenance Chemotherapy, Male, Middle Aged, Neoplasm Staging, Platinum, Vinblastine",

author = "N{\o}r{\o}xe, \{Dorte Schou\} and Sandra Wallerek and S{\o}rensen, \{Jens Benn\}",

year = "2013",

month = aug,

language = "English",

volume = "33",

pages = "3275--8",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "8",

}

TY - JOUR

T1 - Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)

AU - Nørøxe, Dorte Schou

AU - Wallerek, Sandra

AU - Sørensen, Jens Benn

PY - 2013/8

Y1 - 2013/8

N2 - We report on a retrospective, consecutive non-randomized group of patients who received bevacizumab plus chemotherapy without bevazicumab maintenance.

AB - We report on a retrospective, consecutive non-randomized group of patients who received bevacizumab plus chemotherapy without bevazicumab maintenance.

KW - Adult

KW - Aged

KW - Antibodies, Monoclonal, Humanized

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carboplatin

KW - Carcinoma, Non-Small-Cell Lung

KW - Disease-Free Survival

KW - Female

KW - Humans

KW - Kaplan-Meier Estimate

KW - Lung Neoplasms

KW - Maintenance Chemotherapy

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Platinum

KW - Vinblastine

UR - https://www.scopus.com/pages/publications/84883303017

M3 - Journal article

C2 - 23898091

SN - 0250-7005

VL - 33

SP - 3275

EP - 3278

JO - Anticancer Research

JF - Anticancer Research

IS - 8

ER -

Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)

Abstract

Keywords

Other files and links

Fingerprint

Cite this